🔎 Trials Near Me

Почетна › Рак јајника › Misuri › St. Louis

Kliničke studije za Рак јајника u gradu St. Louis, MO

37 studija za Рак јајника traži učesnike na lokacijama u gradu St. Louis i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Тражи се учесникФаза 2/3
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07001748

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Тражи се учесникФаза 3
  • Washington University School of Medicine in St. Louis, St Louis
Узраст 18 и старији · Жене · Ажурирано 12. 11. 2026. · NCT06915025

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • Washington University Medicine, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06270706

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Тражи се учесникФаза 2
  • Washington University School of Medicine, St Louis
  • Mercy Hospital South, St Louis
  • Siteman Cancer Center-South County, St Louis
  • и још 6
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Тражи се учесникФаза 3
  • Washington University School of Medicine ( Site 0052), St Louis
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT06824467

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Тражи се учесникФаза 3
  • Mercy Infusion Center - Chippewa, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy Hospital South, St Louis
  • и још 5
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

Тражи се учесникФаза 1
  • Site 0111, St Louis
Узраст 18 и старији · Жене · Ажурирано 9. 11. 2026. · NCT04516447

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Тражи се учесник
  • Washington University School of Medicine, St Louis
  • Missouri Baptist Medical Center, St Louis
Узраст од 35 до 50 · Жене · Ажурирано 6. 11. 2026. · NCT04251052

The Vanguard Study: Testing a New Way to Screen for Cancer

Тражи се учесникЗдраве особе су добродошле
  • Washington University School of Medicine, St Louis
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Тражи се учесникФаза 1
  • Washington University School of Medicine in St. Louis, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Тражи се учесникФаза 1
  • Washington University School of Medicine in St. Louis, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213791

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Тражи се учесникФаза 1
  • Washington University, Siteman Cancer Center, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Тражи се учесникФаза 1/2
  • Washington Univ. School of Medicine, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Тражи се учесникФаза 1/2
  • Saint Louis University, St Louis
Узраст од 18 до 90 · Оба пола · Ажурирано 28. 10. 2026. · NCT06710756

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Тражи се учесникФаза 2/3
  • Washington University School of Medicine Obstetrics and Gynecology, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06161025

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Тражи се учесникОпсервациона студија
  • Washington University, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT04981119

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 2
  • Washington University, School of Medicine, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Washington University, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Тражи се учесникФаза 2
  • Mercy David C. Pratt Cancer Center /ID# 275655, St Louis
Узраст 18 и старији · Жене · Ажурирано 20. 10. 2026. · NCT06890338

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Тражи се учесник
  • WU St Louis, St Louis
Узраст 18 и старији · Жене · Ажурирано 15. 10. 2026. · NCT05287451

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Тражи се учесникФаза 1/2
  • Washington University, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06799065

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Тражи се учесникФаза 1/2
  • Research Site, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05123482

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Тражи се учесникФаза 2
  • Washington University, St Louis
Узраст од 18 до 99 · Жене · Ажурирано 15. 9. 2026. · NCT07023627

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Тражи се учесникФаза 3
  • Washington University School of Medicine, St Louis
  • Mercy Hospital St. Louis, St Louis
Узраст 18 и старији · Жене · Ажурирано 26. 8. 2026. · NCT05281471

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Тражи се учесникФаза 1/2
  • Washington University School of Medicine, St Louis
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Тражи се учесникФаза 1
  • Normunity Investigational Site, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07182149

IDOV-Immune for Advanced Solid Tumors

Тражи се учесникФаза 1
  • Washington University School of Medicine, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT06910657

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • Investigative Site #110, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 23. 7. 2026. · NCT06545942

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Тражи се учесникФаза 2
  • 521, St Louis
Узраст 18 и старији · Жене · Ажурирано 16. 7. 2026. · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Washington University, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Тражи се учесникФаза 1/2
  • Washington University, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 12. 6. 2026. · NCT06051695

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

Тражи се учесникФаза 1
  • Washington University School of Medicine in St. Louis, St Louis
Узраст 18 и старији · Жене · Ажурирано 28. 5. 2026. · NCT06930755

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

Тражи се учесникФаза 1/2
  • Research site, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 22. 5. 2026. · NCT06386146

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Тражи се учесникФаза 3
  • Washington University School of Medicine, St Louis
Узраст 18 и старији · Жене · Ажурирано 16. 4. 2026. · NCT05659381

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

Тражи се учесник
  • Washington University Medical Center, St Louis
Узраст од 25 до 50 · Жене · Ажурирано 6. 4. 2026. · NCT04294927

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Тражи се учесникФаза 2
  • Washington University, St Louis
Узраст 18 и старији · Жене · Ажурирано 23. 12. 2025. · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, St Louis
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Studije za Рак јајника u drugim gradovima

Ostale studije u gradu St. Louis

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.